{"id":351358,"date":"2019-04-04T21:25:01","date_gmt":"2019-04-04T21:25:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=351358"},"modified":"2019-04-04T21:25:01","modified_gmt":"2019-04-04T21:25:01","slug":"soft-tissue-sarcoma-market-size-is-expected-to-build-at-a-cagr-60-by-2023-global-industry-share-report-trends-competitive-landscape","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/soft-tissue-sarcoma-market-size-is-expected-to-build-at-a-cagr-60-by-2023-global-industry-share-report-trends-competitive-landscape_351358.html","title":{"rendered":"Soft Tissue Sarcoma Market Size is Expected to Build at a CAGR 6.0% By 2023 | Global Industry Share, Report, Trends, Competitive Landscape"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"https:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2019\/04\/1554381671.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"https:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2019\/04\/1554381671.jpeg\" alt=\"\" width=\"225\" height=\"\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;Soft Tissue Sarcoma Market&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Report Title \u201cSoft Tissue Sarcoma Market Research Report &#8211; Global Forecast till 2023\u201d covers detailed competitive outlook and systematic framework of Soft Tissue Sarcoma market at a global uniform platform.<\/div>\n<p><strong>Market Highlights:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/strong><\/p>\n<p>Soft Tissues Sarcoma is the rare and diverse group of cancers that develop from tissues such as blood vessels, muscles, fats, nerves, and deep skin tissues&nbsp;etc. There are around 50 different types of soft tissue sarcoma that are identified, the common types of soft tissue sarcoma include liposarcomas, leiomyosarcomas, and others. The soft tissue sarcoma can be treated by the combined chemotherapy, radiotherapy, and surgery to remove the tumor. If&nbsp;surgical&nbsp;procedure is not required, chemotherapy can be used alone.<\/p>\n<p>Some of the major driving factors&nbsp;includes&nbsp;increasing research and development on biological and targeted drug therapies for&nbsp;the cancer&nbsp;treatment along with the expiration of patents. The increasing healthcare expenditure for quality patient care and various advanced treatments also boost the growth of the global soft tissue sarcoma treatment market. In addition, increasing focus on personalized medicine along with huge investments for anti-cancer treatment research is likely to unveil new paths for soft tissue sarcoma treatment market in the near future.<\/p>\n<p><strong>Get Free Sample copy of Report @&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.marketresearchfuture.com\/sample_request\/5304\">https:\/\/www.marketresearchfuture.com\/sample_request\/5304<\/a><\/strong>&nbsp;<\/p>\n<p><strong>Key Players:<\/strong><\/p>\n<p>Some of key the players in the global soft tissue sarcoma market are GlaxoSmithKline&nbsp;plc. (U.K.), Eli Lilly and Company (U.S.), Pfizer, Inc. (U.S.), Bristol-Myers Squibb (U.S.), F. Hoffmann-La Roche AG (Genentech) (Switzerland), Johnson &amp; Johnson Services, Inc. (U.S.), Teva Pharmaceutical Industries Ltd (Israel), and Celgene Corporation (U.S.) and others.<\/p>\n<p><strong>Segmentation:<\/strong><\/p>\n<p>The soft tissue sarcoma is segmented on the basis of treatment, disease type, distribution channel, and end-users.<\/p>\n<p>On the basis of the treatment type, the soft tissue sarcoma treatment market is segmented into targeted therapy, chemotherapy, anti-angiogenesis drugs, radiation therapy. Furthermore,&nbsp;the radiation&nbsp;therapy is subcategorized into internal radiation therapy and external radiation therapy. On the basis of the disease type, soft tissue sarcoma treatment market is segmented into local sarcoma, regional sarcoma, and metastatic sarcoma. On the basis of the distribution channel, soft tissue sarcoma treatment market is segmented into hospital pharmacies, retail pharmacies and other. On the basis of the end user, the global soft tissue sarcoma treatment market has been segmented into hospitals, oncology centers, and long term care centers.<\/p>\n<p><strong>Regional Analysis:<\/strong><\/p>\n<p>Global soft tissue sarcoma consists of regions namely the Americas, Europe, Asia Pacific, and the Middle East and Africa.<\/p>\n<p>Americas is expected to lead the global market due to&nbsp;high&nbsp;incidence of cancer and soft tissue sarcoma. According to the American Cancer Society, more than 11,400 new cases of soft tissue sarcoma were diagnosed in the U.S. in 2014.&nbsp;While,&nbsp;Europe is expected to hold the second largest market share in the global market.&nbsp;Market&nbsp;in Asia Pacific region is expected to witness significant growth owing to&nbsp;increasing&nbsp;case of cancer and growing awareness regarding advanced cancer treatments. In addition, increasing healthcare expenditure related to cancer and associated disease is expected to boost the market growth in&nbsp;near&nbsp;future.<\/p>\n<p><strong>Get an Exclusive Discount on Report @&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.marketresearchfuture.com\/check-discount\/5304\">https:\/\/www.marketresearchfuture.com\/check-discount\/5304<\/a><\/strong><\/p>\n<p><strong>TABLE OF CONTENT<\/strong><\/p>\n<p><strong>Chapter 1. Report Prologue<\/strong><\/p>\n<p><strong>Chapter 2. Market Introduction<\/strong><\/p>\n<p>2.1 Definition<\/p>\n<p>2.2 Scope Of The Study<\/p>\n<p>2.2.1 Research Objective<\/p>\n<p>2.2.2 Assumptions<\/p>\n<p>2.2.3 Limitations<\/p>\n<p><strong>Chapter 3. Research Methodology<\/strong><\/p>\n<p>3.1 Introduction<\/p>\n<p>3.2 Primary Research<\/p>\n<p>3.3 Secondary Research<\/p>\n<p>3.4 Market Size Estimation<\/p>\n<p><strong>Chapter 4. Market Dynamics<\/strong><\/p>\n<p>4.1 Drivers<\/p>\n<p>4.2&nbsp;Restrains<\/p>\n<p>4.3 Opportunities<\/p>\n<p>4.4 Challenges<\/p>\n<p>4.5 Macroeconomic Indicators<\/p>\n<p>4.6 Treatment Trends &amp; Assessment<\/p>\n<p><strong>Chapter 5. Market Factor Analysis<\/strong><\/p>\n<p>5.1 Porter&rsquo;s Five Forces Analysis<\/p>\n<p>5.1.1 Bargaining Power Of Suppliers<\/p>\n<p>5.1.2 Bargaining Power Of Buyers<\/p>\n<p>5.1.3 Threat Of New Entrants<\/p>\n<p>5.1.4 Threat Of Substitutes<\/p>\n<p>5.1.5 Intensity Of Rivalry<\/p>\n<p>5.2 Value Chain Analysis<\/p>\n<p>5.3 Investment Feasibility Analysis<\/p>\n<p>5.4 Pricing Analysis<\/p>\n<p><strong><em>Browse Full Report @<\/em><\/strong><strong>&nbsp;<\/strong><a rel=\"nofollow\" href=\"https:\/\/www.marketresearchfuture.com\/reports\/soft-tissue-sarcoma-market-5304\"><em>https:\/\/www.marketresearchfuture.com\/reports\/soft-tissue-sarcoma-market-5304<\/em><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/marketresearchfuture.com\/reports\/soft-tissue-sarcoma-market-5304_36734.html\" rel=\"nofollow\">Market Research Future<\/a><br \/><strong>Contact Person:<\/strong> Abhishek Sawant<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=soft-tissue-sarcoma-market-size-is-expected-to-build-at-a-cagr-60-by-2023-global-industry-share-report-trends-competitive-landscape\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +1 646 845 9312<br \/><strong>Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar  <br \/><strong>City:<\/strong> Pune<br \/><strong>State:<\/strong> Maharashtra<br \/><strong>Country:<\/strong> India<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.marketresearchfuture.com\/reports\/soft-tissue-sarcoma-market-5304\" target=\"_blank\" rel=\"nofollow\">www.marketresearchfuture.com\/reports\/soft-tissue-sarcoma-market-5304<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=soft-tissue-sarcoma-market-size-is-expected-to-build-at-a-cagr-60-by-2023-global-industry-share-report-trends-competitive-landscape\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Soft Tissue Sarcoma Market&#8221; Report Title \u201cSoft Tissue Sarcoma Market Research Report &#8211; Global Forecast till 2023\u201d covers detailed competitive outlook and systematic framework of Soft Tissue Sarcoma market at a global uniform platform. Market Highlights:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Soft Tissues Sarcoma is &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/soft-tissue-sarcoma-market-size-is-expected-to-build-at-a-cagr-60-by-2023-global-industry-share-report-trends-competitive-landscape_351358.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-351358","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/351358","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=351358"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/351358\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=351358"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=351358"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=351358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}